Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.01M Sell
66,602
-21,995
-25% -$2.54M 0.1% 153
2025
Q4
$9.33M Buy
88,597
+24,306
+38% +$2.28M 0.11% 145
2025
Q3
$5.43M Buy
64,291
+9,053
+16% +$746K 0.08% 195
2025
Q2
$4.44M Sell
55,238
-5,682
-9% -$452K 0.07% 229
2025
Q1
$5.47M Sell
60,920
-24,850
-29% -$2.32M 0.1% 173
2024
Q4
$8.53M Buy
85,770
+4,033
+5% +$416K 0.15% 126
2024
Q3
$9.28M Buy
81,737
+7,277
+10% +$865K 0.17% 125
2024
Q2
$9.22M Sell
74,460
-4,097
-5% -$528K 0.2% 111
2024
Q1
$10.1M Buy
78,557
+7,605
+11% +$937K 0.23% 109
2023
Q4
$7.74M Buy
70,952
+12,413
+21% +$1.29M 0.2% 114
2023
Q3
$6.03M Buy
58,539
+2,267
+4% +$244K 0.19% 121
2023
Q2
$6.49M Sell
56,272
-1,942
-3% -$220K 0.22% 112
2023
Q1
$6.19M Buy
58,214
+4,121
+8% +$445K 0.24% 101
2022
Q4
$6M Buy
54,093
+4,551
+9% +$465K 0.26% 96
2022
Q3
$4.27M Sell
49,542
-8,301
-14% -$741K 0.2% 113
2022
Q2
$5.27M Buy
57,843
+50,274
+664% +$4.46M 0.24% 103
2022
Q1
$621K Buy
7,569
+3,827
+102% +$302K 0.03% 274
2021
Q4
$287K Sell
3,742
-973
-21% -$77.5K 0.01% 345
2021
Q3
$354K Buy
4,715
+796
+20% +$60.5K 0.02% 236
2021
Q2
$305K Buy
+3,919
New +$291K 0.02% 241

Other funds holding MRK

NewEdge Wealth's MRK Position: Q1 2026 in Review

NewEdge Wealth reduced its Merck (MRK) stake by 25% in Q1 2026, selling an estimated $2.54M and leaving 66,602 shares worth $8.01M. The position accounts for 0.1% of the portfolio, ranked #153.

NewEdge Wealth first reported a position in MRK in Q2 2021 and has held it in 20 quarters since. The position peaked at $10.1M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • NewEdge Wealth held 66,602 shares of Merck worth $8.01M as of Q1 2026.
  • NewEdge Wealth sold 21,995 Merck shares in Q1 2026, an estimated $2.54M.
  • Merck made up 0.1% of NewEdge Wealth's portfolio in Q1 2026, its #153 holding.
  • NewEdge Wealth first reported a position in Merck in Q2 2021 and has held it in 20 quarters since.
  • NewEdge Wealth's Merck position peaked at $10.1M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.